论文部分内容阅读
目的明确复方福尔可定口服液的疗效方法把200例支气管肺炎患儿平均分成两组,治疗组采用口服复方福尔可定口服液,对照组给予口服其他止咳化痰药物对比(两组均常规给予静脉滴注头孢菌素或大环内酯类抗生素和抗病毒药物等)。结果治疗组疗效明显高于对照组,治疗组总有效率96.7,对照组为83.75%。结论复方福尔可定口服液治疗支气管肺炎疗效优于其他止咳化痰药。
Objective To determine the curative effect of Fufang Erding oral liquid in 200 patients with bronchial pneumonia, divide the patients into two groups equally, treat the patients with oral Fufang Erding oral liquid, and the control group with oral administration of other cough and phlegm drugs (both groups Conventional intravenous cephalosporin or macrolide antibiotics and antiviral drugs, etc.). Results The treatment group was significantly higher than the control group, the total effective rate was 96.7 in the treatment group and 83.75% in the control group. Conclusion Fufang Erding oral solution in the treatment of bronchial pneumonia is better than other cough and phlegm drugs.